Lukatch Heath has filed 20 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 3041 shares of Vaxcyte, Inc. ($PCVX) on June 12, 2025.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | A | Common Stock | 3041 | $0.00 | 17,216.0000 | 121,997,348 | 21.45% | 0.00% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | A | Stock Option (right to buy) | 15372 | $0.00 | 15,372.0000 | 121,997,348 | 9999.99% | 0.01% |
| April 8, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Common Stock | 6000 | $16.00 | 13,175.0000 | 121,997,348 | 83.62% | 0.00% |
| April 8, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Common Stock | 1000 | $21.49 | 14,175.0000 | 121,997,348 | 7.59% | 0.00% |
| April 8, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Stock Option (right to buy) | 6000 | $0.00 | 14,000.0000 | 121,997,348 | 30.00% | 0.00% |
| April 8, 2025 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Stock Option (right to buy) | 1000 | $0.00 | 14,000.0000 | 121,997,348 | 6.67% | 0.00% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | A | Common Stock | 1550 | $0.00 | 7,175.0000 | 97,157,690 | 27.56% | 0.00% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | A | Stock Option (right to buy) | 7250 | $0.00 | 7,250.0000 | 97,157,690 | 9999.99% | 0.01% |
| Jan. 31, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | M | Common Stock | 5000 | $16.00 | 10,625.0000 | 97,157,690 | 88.89% | 0.01% |
| Jan. 31, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | S | Common Stock | 5000 | $71.50 | 5,625.0000 | 97,157,690 | 47.06% | 0.01% |
| Jan. 31, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | M | Stock Option (right to buy) | 5000 | $0.00 | 6,000.0000 | 97,157,690 | 45.45% | 0.01% |
| Jan. 29, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | M | Common Stock | 4000 | $16.00 | 9,625.0000 | 97,157,690 | 71.11% | 0.00% |
| Jan. 29, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | S | Common Stock | 4000 | $67.50 | 5,625.0000 | 97,157,690 | 41.56% | 0.00% |
| Jan. 29, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Not found | M | Stock Option (right to buy) | 4000 | $0.00 | 11,000.0000 | 97,157,690 | 26.67% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Common Stock | 13000 | $16.00 | 18,625.0000 | 97,157,690 | 231.11% | 0.01% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | S | Common Stock | 1101 | $62.85 | 17,524.0000 | 97,157,690 | 5.91% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | S | Common Stock | 7444 | $63.55 | 10,080.0000 | 97,157,690 | 42.48% | 0.01% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | S | Common Stock | 4164 | $64.28 | 5,916.0000 | 97,157,690 | 41.31% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | S | Common Stock | 291 | $65.19 | 5,625.0000 | 97,157,690 | 4.92% | 0.00% |
| Jan. 2, 2024 | Vaxcyte, Inc. | $PCVX | Lukatch Heath | Director | M | Stock Option (right to buy) | 13000 | $0.00 | 15,000.0000 | 97,157,690 | 46.43% | 0.01% |